Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Apr;8(2):93-102.

Economic burden of opioid-induced constipation among long-term opioid users with noncancer pain

Yin Wan  1 , Shelby Corman  2 , Xin Gao  3 , Sizhu Liu  4 , Haridarshan Patel  5 , Reema Mody  6
Affiliations

Economic burden of opioid-induced constipation among long-term opioid users with noncancer pain

Yin Wan et al. Am Health Drug Benefits. 2015 Apr.

Abstract

Background: Opioid-induced constipation (OIC) can be a debilitating side effect of opioid therapy and may result in increased medical costs. The published data on the economic burden of OIC among long-term opioid users are limited.

Objective: To assess the economic burden of OIC in patients with noncancer pain in a managed care population in the United States.

Methods: This retrospective study used 2007-2011 data from the Truven Health MarketScan Commercial and Medicare databases. The study included adults with ≥12 months of insurance enrollment before and after starting long-term (≥90 days) use of opioids. Patients were excluded if they had cancer or a diagnosis of drug abuse or drug dependence during the study period, or if they had constipation or bowel obstruction within 90 days before starting opioid therapy during the study period. OIC was identified by International Classification of Diseases, Ninth Edition codes for constipation (564.0) or bowel obstruction (560.x) within 12 months of the initiation of an opioid. Patients with OIC were identified in the nonelderly, elderly (age ≥65 years), and long-term care populations. Differences in costs and healthcare resource utilization were calculated using propensity scoring.

Results: A total of 13,808 nonelderly (age, 48.6 ± 10.4 years; female, 50%) and 2958 elderly patients (age, 78.7 ± 8.1 years; female, 70%) met the study inclusion criteria. Of 401 nonelderly and 194 elderly patients with OIC, 85 patients initiated opioid therapy in a long-term care facility (age, 80.7 ± 11.6 years; female, 77%). After matching by key covariates, patients with OIC had significantly more hospital admissions than patients without OIC (nonelderly, 33% vs 22%, respectively; P <.001; elderly, 51% vs 31%, respectively; P <.001) and longer inpatient stays (nonelderly, 3.0 ± 8.4 days vs 1.0 ± 3.0 days, respectively; P <.001; elderly, 5.2 ± 12.2 days vs 2.1 ± 4.0 days, respectively; P <.001). The group with OIC had significantly higher total healthcare costs than the group without OIC in all 3 study cohorts (nonelderly, $23,631 ± $67,209 vs $12,652 ± $19,717, respectively; elderly, $16,923 ± $38,191 vs $11,117 ± $19,525, respectively; long-term care, $16,000 ± $22,897 vs $14,437 ± $25,690, respectively; all P <.05).

Conclusion: To the best of our knowledge, this is the first study to analyze the economic impact of long-term use of opioids among patients with OIC, using real-world data. The findings underscore the significant economic burden associated with long-term opioid use for noncancer pain in a managed care population. Effective therapies for OIC may reduce the associated economic burden and improve quality of life for long-term opioid users.

Keywords: constipation; economic burden; elderly; healthcare resource utilization; long-term care; long-term opioid use; opioid-induced constipation; pain management.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Study Design
Figure 2
Figure 2. Flowchart of Cohort Selection with Sample Size
Figure 3
Figure 3. Total Costs and Cost Components in Nonelderly Patients, by Constipation Statusa
Figure 4
Figure 4. Total Costs and Cost Components in Elderly Patients, by Constipation Statusa
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Trescot A, Glaser SE, Hansen H. Effectiveness of opioids in the treatment of chronic non-cancer pain. Pain Physician. 2008; 11: S181–S200. - PubMed
    1. Dorn SD, Meek PD, Shah ND. Increasing frequency of opioid prescriptions for chronic abdominal pain in US outpatient clinics. Clin Gastroenterol Hepatol. 2011; 9: 1078–1085.e1. Erratum in: Clin Gastroenterol Hepatol. 2012; 10: 332. - PubMed
    1. Moore RA, McQuay HJ. Prevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomised trials of oral opioids. Arthritis Res Ther. 2005; 7: R1046–R1051. - PMC - PubMed
    1. Bell T, Milanova T, Grove G, et al. OBD symptoms impair quality of life and daily activities, regardless of frequency and duration of opioid treatment: results of a US patient survey (PROBE survey). J Pain. 2007; 8(4 suppl 1). Abstract 882.
    1. Singh G, Kahler K, Bharathi V, et al. Constipation in adults: complications and comorbidities. Gastroenterology. 2005; 128(4 suppl 2). Abstract S960.

LinkOut - more resources